Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients.

Cancers (Basel) · 2024 · PMC11487387 · PMID 38792012

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Continuous infusion showed a trend toward clinical improvement, although it did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

In the analysis of all-cause mortality for the different beta-lactam arm, newer publication years showed a trend favoring the combination of beta-lactam with aminoglycosides.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.